Thelansis

Complex regional pain syndrome (CRPS), or Sudeck's dystrophy or reflex sympathetic dystrophy, is a painful condition characterized by various symptoms, including pain, sensory disturbances, Sudo- and vasomotor abnormalities, trophic changes, and impaired motor function. CRPS can develop due to different levels or types of tissue damage. In some cases, it has even been observed without any injury, often arising from extended periods of immobilization. Among the most common causes of CRPS is a fracture, while surgery is another frequent trigger. Other injuries or insults that can incite CRPS encompass sprains, contusions, crush injuries, and surgical procedures. CRPS is categorized into two main types: type I, formerly known as reflex sympathetic dystrophy, and type II, previously termed causalgia. Type I occurs without associated nerve trauma, whereas type II arises following known nerve injuries. Additionally, CRPS is further subdivided into "warm" versus "cold"...

  Complex regional pain syndrome (CRPS), also known as Sudecks dystrophy or reflex sympathetic dystrophy, is a painful disease characterised by pain, sensory, Sudo- and vasomotor disturbances, trophic changes, and impaired motor function. CRPS patients are treated by physicians from various clinical backgrounds, including anaesthesiologists, (orthopaedic) surgeons, neurologists, rheumatologists, and rehabilitation centres, due to the complexity and broad spectrum of symptoms. The prevalence of CRPS varied between 7.68 to 27.1 cases per 100,000 population in 2020. Thelansis’s “Complex Regional Pain Syndrome (CRPS) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Complex Regional Pain Syn...